Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1994-8-12
pubmed:abstractText
Cytogenetic analysis of a pediatric patient with T-cell acute lymphoblastic leukemia (T-ALL) revealed a mosaic karyotype, 47,XX,+17,t(11;14)(p13;q11)/47,XX,+17,t(9;22)(q34;q11),t(11;14) (p13;q11). DNA blot analysis was used to examine the break-point within the BCR gene on chromosome 22 and showed that the breakpoint occurred within the 20-kb minor breakpoint cluster region (m-bcr) located within the first intron of the BCR gene. Immunoprecipitation analysis demonstrated that the leukemic cells expressed the P185 BCR-ABL protein tyrosine kinase. P185 BCR-ABL has previously been shown to be expressed in most cases of Ph+ acute leukemia of myeloid and B-progenitor origin. Here, we demonstrate for the first time that P185 can also be expressed in the T-cell lineage. DNA blot hybridization was also used to characterize the t(11;14) translocation. This showed rearrangement on chromosome 11 within the T-ALLbcr region, upstream of the RBTN-2 gene. Polymerase chain reaction revealed the presence of RBTN-2 transcripts in the leukemic cells. Finally, comparison of the T-ALLbcr, BCR-ABL, IGH, TCR beta and gamma gene rearrangements in leukemic cells obtained at the time of diagnosis and at first relapse showed that relapse occurred in a leukemic clone indistinguishable from the major Ph+ clone involved at diagnosis. Together, these data support a multistep pathogenesis in which the Philadelphia (Ph) chromosome translocation appeared subsequent to the +17 and t(11;14) and imparted a growth advantage over the Ph-negative cells that carried these abnormalities.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0887-6924
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:geneSymbol
IGH, RBTN-2
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1124-30
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:8035604-Base Sequence, pubmed-meshheading:8035604-Child, pubmed-meshheading:8035604-Chromosomes, Human, Pair 11, pubmed-meshheading:8035604-Chromosomes, Human, Pair 14, pubmed-meshheading:8035604-DNA, Neoplasm, pubmed-meshheading:8035604-DNA-Binding Proteins, pubmed-meshheading:8035604-Female, pubmed-meshheading:8035604-Gene Expression, pubmed-meshheading:8035604-Genes, abl, pubmed-meshheading:8035604-Humans, pubmed-meshheading:8035604-Immunoblotting, pubmed-meshheading:8035604-Immunophenotyping, pubmed-meshheading:8035604-Karyotyping, pubmed-meshheading:8035604-LIM Domain Proteins, pubmed-meshheading:8035604-Leukemia-Lymphoma, Adult T-Cell, pubmed-meshheading:8035604-Molecular Sequence Data, pubmed-meshheading:8035604-Oncogene Proteins, pubmed-meshheading:8035604-Philadelphia Chromosome, pubmed-meshheading:8035604-RNA, Neoplasm, pubmed-meshheading:8035604-Transcription Factors, pubmed-meshheading:8035604-Translocation, Genetic
pubmed:year
1994
pubmed:articleTitle
Simultaneous expression of RBTN-2 and BCR-ABL oncogenes in a T-ALL with a t(11;14)(p13;q11) and a late-appearing Philadelphia chromosome.
pubmed:affiliation
Department of Human Oncology, University of Wisconsin, Madison 53792.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Case Reports, Research Support, Non-U.S. Gov't